Category

UF Innovate | Accelerate

Unlocking Your Business Potential

Maybe you’re considering your company's +1 or more, knowing it’s time for expansion. If so, now is the time to make significant changes to reach your business’s potential. In today’s hack, UF Innovate | Accelerate Director Karl LaPan will tell you how.

Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics

BARDA is awarding over $240 million to support Project NextGen clinical studies for COVID-19 vaccines, including investments in cold-chain sample management, genomic sequencing, and increased central laboratory capacity for sample testing. UF Innovate | Accelerate client BioInfoExperts is among the recipients. BARDA provided $4 million to the startup to provide genomic sequencing of COVID-19.

National Cade Prize for Innovation Names 21 Finalists

Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci Finalists. Finalists will compete to win $10,000 in their respective category group—Agriculture and Environmental, Healthcare/Biomedical, IT/Tech, Energy, and Wildcard. One of the five category winners will be selected as the Inventivity™ Grand Prize winner and take home an additional $50,000 prize. Two UF startups -- Lactovid and Analyz -- are listed among the Fibonacci Finalists.

For the 2nd Year in a Row, Admiral Makes the Inc. 5000

Inc. revealed today that UF Accelerate client resident Admiral, The Visitor Relationship Management (VRM) Company, was named for a second year in a row to the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses.

Oragenics, Inc. Announces Private Placement

Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.